A detailed history of Edbi Pte LTD transactions in I Mab stock. As of the latest transaction made, Edbi Pte LTD holds 222,136 shares of IMAB stock, worth $215,471. This represents 0.37% of its overall portfolio holdings.

Number of Shares
222,136
Previous 222,136 -0.0%
Holding current value
$215,471
Previous $370,000 25.68%
% of portfolio
0.37%
Previous 0.42%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 25, 2022

BUY
$45.28 - $74.5 $10.1 Million - $16.5 Million
222,136 New
222,136 $10.5 Million

Others Institutions Holding IMAB

About I-Mab


  • Ticker IMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,098,800
  • Market Cap $80.6M
  • Description
  • I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...
More about IMAB
Track This Portfolio

Track Edbi Pte LTD Portfolio

Follow Edbi Pte LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edbi Pte LTD, based on Form 13F filings with the SEC.

News

Stay updated on Edbi Pte LTD with notifications on news.